Solutions / Clinical Services
Clinical Services
Our Clinical Team leverages a multitude of tools and strategies to help clients understand and manage their pharmacy spend. Please review some of our clinical solutions below and connect with the Gateway Clinical Team to learn more.
Message from Azim
“It’s very easy to become overwhelmed with all the news and happenings in the pharmaceutical industry. This is why our clients receive a curated weekly newsletter informing them of the top 1-2 news stories that may be important to them. The newsletter reaches everyone from Chief Medical Officers, brokers, consultants, human resources, staff and clinical pharmacists. Learn more about how we support our clients.”
Azim Bari
GHP Chief Clinical Officer
GHP Clinical Resources
FDA Announcements
FDA Approves Drug with New Mechanism of Action for Treatment
of Schizophrenia
Today, the U.S. Food and Drug Administration approved Cobenfy (xanomeline and trospium chloride) capsules for oral use for the treatment of schizophrenia in adults. It is the first antipsychotic drug approved to treat schizophrenia that targets cholinergic receptors as opposed to dopamine receptors, which has long been the standard of care.
FDA Approves Drug with New Mechanism of Action for Treatment of Schizophrenia | FDA
Health & Wellness
Declining senses can impact mental health and loneliness in aging adults
Most people — up to 94% of U.S. adults — experience at least some dulling of their senses with age, finding themselves squinting at screens, craving stronger flavors, and missing snatches of conversations more and more frequently. Researchers at the University of Chicago Medicine are looking into how these changes can go beyond mere inconvenience and actually worsen overall mental health in older adults.
Declining senses can impact mental health and loneliness in aging adults – UChicago Medicine
Understanding Medical Lingo and Jargon
Cardiology “Cardio” relating to the heart
Ology the study of
Hepat(o) liver
Hyper excessive, high
Hypo deficient, low